Free shipping on all orders over $ 500

PFI-1

Cat. No. M2932

All AbMole products are for research use only, cannot be used for human consumption.

PFI-1  Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 35 In stock
5mg USD 50 In stock
10mg USD 85 In stock
50mg USD 240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM.

Customer Product Validations & Biological Datas
Source Sci Rep (2017). Figure 1. PFI-1
Method flow cytometry
Cell Lines C11 cells or A10.6 cells
Concentrations 5 μM
Incubation Time 24 to 72 h
Results To determine the effect of RVX-208 and PFI-1 on latent HIV-1 reactivation, we used J-Lat C11 cell line in which transcriptional activation of the latent provirus can be detected in individual cells by flow cytometry, since these cells harbor full-length latent HIV-1 provirus containing GFP gene in place of nef
Chemical Information
Molecular Weight 347.39
Formula C16H17N3O4S
CAS Number 1403764-72-6
Solubility (25°C) DMSO 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Esteban Quezada, et al. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model

[2] Bianca Altenburg, et al. Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies

[3] Marie C Hupe, et al. The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells

[4] Panpan Lu, et al. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency

[5] Sarah Picaud, et al. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains

Related Epigenetic Reader Domain Products
RVX-208

Apabetalone (RVX-208) is a first-in-class, small molecule inhibitor of BET bromodomain with IC50 of 0.51 μM for BD2.

I-BET151

I-BET151 (GSK1210151A) is an inhibitor of the BET family with IC50 of 0.5 μM, 0.25 μM and 0.79 μM for BRD2, BRD3 and BRD4, respectively.

(+)-JQ1

(+)-JQ1 is a BET bromodomain inhibitor that acts on BRD4(2) with an IC50 of 33 nM and binds to all bromodomain domains in the BET family, but not to bromodomain domains outside the BET family. JQ1 down-regulates CD47 expression through a C-MYC-mediated pathway, and JQ1 down-regulates CD47 expression through a C-MYC-mediated pathway.

I-BET-762

I-BET-762 (GSK525762) is a selective small molecule BET inhibitor.

CPI-0610

CPI-0610 is a novel BET protein bromodomain inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: PFI-1 supplier, Epigenetic Reader Domain, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.